You just read:

FDA Grants Orphan Drug Designation for Bayer's Investigational Ciprofloxacin DPI (Dry Powder for Inhalation) for Treatment of Non-Cystic Fibrosis Bronchiectasis

News provided by

Bayer HealthCare

22 Apr, 2014, 17:05 ET